GAM
DGX icon

Generali Asset Management’s Quest Diagnostics DGX Stock Holding History

Generali Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Sell
15,146
-6,932
-31% -$1.36M 0.06% 240
2026
Q1 		$4.33M Buy
22,078
+2,156
+11% +$419K 0.09% 202
2025
Q4 		$3.46M Buy
19,922
+8,924
+81% +$1.63M 0.07% 228
2025
Q3 		$2.1M Buy
10,998
+339
+3% +$60.2K 0.04% 299
2025
Q2 		$1.91M Sell
10,659
-15,958
-60% -$2.77M 0.04% 323
2025
Q1 		$4.5M Sell
26,617
-3,014
-10% -$495K 0.11% 184
2024
Q4 		$4.47M Buy
+29,631
New +$4.61M 0.11% 178

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Generali Asset Management's DGX Position: Q2 2026 in Review

Generali Asset Management reduced its Quest Diagnostics (DGX) stake by 31% in Q2 2026, selling an estimated $1.36M and leaving 15,146 shares worth $3.21M. The position accounts for 0.06% of the portfolio, ranked #240.

Generali Asset Management first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.5M in Q1 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Generali Asset Management held 15,146 shares of Quest Diagnostics worth $3.21M as of Q2 2026.
  • Generali Asset Management sold 6,932 Quest Diagnostics shares in Q2 2026, an estimated $1.36M.
  • Quest Diagnostics made up 0.06% of Generali Asset Management's portfolio in Q2 2026, its #240 holding.
  • Generali Asset Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Quest Diagnostics position peaked at $4.5M in Q1 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.